Showing results (451-460 of 476) with videos related to

Sort By:
Pageof 48
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 28, 2024
Benefit of early oseltamivir therapy for adults hospitalized with influenza A: an observational studyNathaniel M Lewis, Elizabeth J Harker, Lauren B Grant, et al.
JAMA Network Open|April 4, 2024
Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US AdultsDiya Surie, Katharine A Yuengling, Jennifer DeCuir, et al.
Annals of Internal Medicine|December 20, 2021
Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial, Jens D Lundgren, Birgit Grund, et al.
MMWR. Morbidity and Mortality Weekly Report|February 27, 2025
Interim Estimates of 2024-2025 Seasonal Influenza Vaccine Effectiveness - Four Vaccine Effectiveness Networks, United States, October 2024-February 2025Aaron M Frutos, Seana Cleary, Emily L Reeves, et al.
JAMA|November 4, 2021
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease SeverityMark W Tenforde, Wesley H Self, Katherine Adams, et al.
MMWR. Morbidity and Mortality Weekly Report|August 26, 2021
Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021Mark W Tenforde, Wesley H Self, Eric A Naioti, et al.
MMWR. Morbidity and Mortality Weekly Report|January 27, 2022
Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021Mark W Tenforde, Manish M Patel, Manjusha Gaglani, et al.
Medrxiv : the Preprint Server for Health Sciences|June 23, 2022
Vaccine Effectiveness of Primary Series and Booster Doses against Omicron Variant COVID-19-Associated Hospitalization in the United StatesKatherine Adams, Jillian P Rhoads, Diya Surie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 8, 2022
Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United StatesNathaniel M Lewis, Wesley H Self, Manjusha Gaglani, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2021
Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United StatesMark W Tenforde, Manish M Patel, Adit A Ginde, et al.
Pageof 48